A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

A team from the Wistar Institute has demonstrated the role of Parkin—a protein implicated in Parkinson's disease—in the ...

Public health advocates and farmworkers called for a federal ban on a toxic herbicide they say led to their Parkinson’s ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

An intelligent self-adjusting brain pacemaker could improve the quality-of-life for those living with Parkinson’s disease ...

Higher air pollution levels, particularly PM2.5 and NO2, significantly increase the risk of Parkinson's disease and worsen ...

A renowned chemist and professor from Nainital has claimed making major headway in finding a cure and treatment for Parkinson ...